이상반응 보고
| VAERS ID | 2296883 |
|---|---|
| 성별 | 여성 |
| 나이 | |
| 주 코드 | FR |
| 제약회사 | PFIZER\BIONTECH |
| 로트 번호 | EX8680 |
| 예방접종 횟수 | 1 |
| 접종일 | 2021-05-11 |
| 발병일 | |
| 상태 |
증상
- 임신 중 모성 노출(Maternal exposure during pregnancy)
- 헬프 증후군(HELLP syndrome)
이환 중 질병
지병
Medical History/Concurrent Conditions: Pregnancy
기타 의료
이전 예방접종
알레르기
임상 검사
증상 상세
HELLP syndrome; Maternal Exposure During Pregnancy, third trimester; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from the regulatory authority.
Regulatory number: DE-PEI-CADR2021076680.
Other Case identifier(s): DE-CADRPEI-2021076680, DE-PEI-202200025227.
A 30-year-old female patient (pregnant) received BNT162b2 (COMIRNATY), on 11May2021 as dose 1, single (Lot number: EX8680) for covid-19 immunisation.
The patient's relevant medical history included: "Pregnancy" (unspecified if ongoing).
The patient was 7 months pregnant at the event onset.
The patient's concomitant medications were not reported.
The following information was reported: HELLP SYNDROME (medically significant), outcome "unknown"; MATERNAL EXPOSURE DURING PREGNANCY (medically significant), outcome "unknown", described as "Maternal Exposure During Pregnancy, third trimester".
No follow-up attempts are possible.
No further information is expected.
Sender comment: Do you or the person concerned have any known allergies? If so, what are they? None.
Details of risk factors or previous illnesses Pregnancy/vaccination in the 30th week of pregnancy with BioNTech and parallel Boostrix AC37B356AB.
Result of assessment: The result of assessment for reported event HELLP syndrome was D.
Unclassified.
No follow-up attempts are possible.
No further information is expected.